Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

3 years ago

INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with…

electroCore, Inc. Announces Departure of JP Errico from the Board of Directors

3 years ago

ROCKAWAY, N.J., May 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced…

COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference

3 years ago

LONDON, May 26, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating…

Results of the votes of the Combined Shareholders’ General Meeting of May 25, 2023

3 years ago

  Daix (France), Long Island City (New York, United States), May 26, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA),…

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS

3 years ago

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000…

Guerbet: Changes in Guerbet’s Board of Directors

3 years ago

Changes in Guerbet's Board of Directors Appointment of Didier Izabel as Chair of the Board of DirectorsAppointment of Pascale Auger…

BBS-Bioactive Bone Substitutes Plc – Inside information – Positive decision received on the product classification, schedule for the quality system approval to be updated

3 years ago

BBS-Bioactive Bone Substitutes Plc, Company announcement, Insider information, 26 May 2023 at 5:30 p.m. EEST BBS-Bioactive Bone Substitutes Plc – Inside information – Positive…

Nexcella Announces Commencement of NXC-201 Engineering Batches at its U.S. CAR-T Manufacturing Site

3 years ago

U.S. engineering batches support planned expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial to the United States Engineering…

Immix Biopharma Subsidiary Nexcella Announces Commencement of NXC-201 Engineering Batches at its U.S. CAR-T Manufacturing Site

3 years ago

U.S. engineering batches support planned expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial to the United States Engineering…

Smart for Life Announces Successful Debt Refinancing as Part of Company’s Balance Sheet Transformation

3 years ago

Conversion Includes Over $5.8 Million of Debt into Equity and Over $1.2 Million by Executive Management and the Board of…